Endoscopy 2008; 40(10): 849-854
DOI: 10.1055/s-2008-1077593
DDW highlights

© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic ultrasound

D.  Gilbert1 , I.  D.  Penman1
  • 1Gastroenterology Unit, Western General Hospital, Edinburgh, EH4 2XU, UK
Further Information

Publication History

Publication Date:
30 September 2008 (online)

Introduction

Endoscopic ultrasound (EUS) continues to challenge the boundaries of current applications in clinical practice, but as we anticipate new therapeutic roles in linear-array EUS, challenges remain in established diagnostic roles, especially in relation to pancreatic disease. With parallel advances in endoscopic and cross-sectional imaging, re-evaluation of the role of EUS in cancer staging is also necessary. Furthermore, quality and safety issues are increasingly being highlighted. A focused review of the important themes emerging from this year’s DDW meeting is presented here.

References

  • 1 Muthusamy R, Rastogi A, Edmundowicz S. et al . The utility of EUS in patients with Barretts oesophagus and high grade dysplasia: analysis of the AIM Dysplasia Trial experience.  Gastrointest Endosc. 2008;  67 AB99
  • 2 Pech O, Guenter E, Dusemund F. et al . Value of high frequency miniprobes and conventional radial EUS in the staging of early Barrett’s carcinoma: a randomised prospective controlled trial with a cross over design.  Gastrointest Endosc. 2008;  67 AB198
  • 3 Nguyen T, Lee C, Whang C. et al . A comparison of the diagnostic yield and specimen adequacy between 22 and 25 gauge needles for EUS guided FNA of solid pancreatic lesions: is bigger better?.  Gastrointest Endosc. 2008;  67 AB100
  • 4 Gill K, Al-Haddad M, Krishna M. et al . Cytologic evaluation of cystic pancreatic lesions: comparison of echobrush vs standard EUS-FNA techniques in a blinded prospective study.  Gastrointest Endosc. 2008;  67 AB97
  • 5 Hocke M, Dietrich C, Stallmach A. The use of contrast enhanced EUS in discrimination between focal pancreatitis and pancreatic cancer.  Gastrointest Endosc. 2008;  67 AB200-AB201
  • 6 Ohno E, Hirooka Y, Itoh A. et al . Usefulness of contrast enhanced EUS in the diagnosis of mural nodules in IPMN’s of the pancreas. The comparison of the CE-EUS findings with the pathological findings.  Gastrointest Endosc. 2008;  67 AB209
  • 7 Saftoiu A, Vilmann P, Gorunescu F. et al . Neural network analysis of dynamic sequences of EUS elastography used for the differential diagnosis of chronic pancreatitis and pancreatic cancer.  Gastrointest Endsosc. 2008;  67 AB97
  • 8 Gonda T, Shah S, Stavropoulos S. et al . Use of molecular markers in clinically low risk cystic lesions of the pancreas.  Gastrointest Endosc. 2008;  67 AB217
  • 9 Zolotarevsky E, Kwon R, Elta G. et al . Fluid CEA level is more influential than DNA mutational analysis in guiding clinical management of pancreatic cystic lesions.  Gastrointest Endosc. 2008;  67 AB214
  • 10 Wang D, Jin Z, Li Z. et al . Measuring mesothelin protein level in EUS guided FNA specimens – a novel method in pancreatic adenocarcinoma detection.  Gastrointest Endosc. 2008;  67 AB96
  • 11 Hernandez L, Sahai A, Brugge W. et al . Standardized weighted criteria for EUS features of chronic pancreatitis: the Rosemount Classification.  Gastrointest Endsoc. 2008;  67 AB96
  • 12 Catalano M, Hernandez L, Kaul V. et al . EUS diagnosis of chronic pancreatitis: Comparison of the current criteria versus the new ”Rosemount criteria“ developed by an international consensus conference.  Gastrointest Endosc. 2008;  67 AB215
  • 13 Varadarajulu S, Christein J, Tamhane A. et al . Prospective randomized trial comparing EUS and gastroscopy for transmural drainage of pancreatic cysts.  Gastrointest Endosc. 2008;  67 AB110
  • 14 Maranki J, Shami V, Hernandez A. et al . Interventional EUS-guided cholangiography: long term experience of an emerging alternative to percutaneous transhepatic cholangiography.  Gastrointest Endosc. 2008;  67 AB224
  • 15 Sanders M, Khalid A, Fasanella K. et al . EUS-guided fiducial placement for stereotactic radiosurgery in pancreatic cancer.  Gastrointest Endosc. 2008;  67 AB201
  • 16 Meenan J, Mesenas S, Mahon B. et al . Multicenter feasibility study on the use of an EUS-delivered P32-labeled liquid based brachytherapy implant in advanced pancreatic cancer.  Gastrointest Endosc. 2008;  67 AB109
  • 17 Muthusamy R, Ashida R, Lee J. et al . The safety and feasibility of EUS-guided fine needle injection of local biologic anti-tumor agents in patients with advanced pancreatic carcinoma.  Gastrointest Endosc. 2008;  67 AB109-AB110
  • 18 Coe S, Raimondo M, Woodward T. et al . Quality in EUS: an assessment of baseline compliance and performance improvement using the ASGE-ACG quality indicators.  Gastrointest Endosc. 2008;  67 AB206
  • 19 Cleveland P, Coe S, Woodward T. et al . Validation of ASGE quality metrics in EUS: association with clinical outcomes.  Gastrointest Endosc. 2008;  67 AB197-198
  • 20 Whang C, Lee C, Thong N. et al . In patients with Barrett’s esophagus (BE) and high grade dysplasia (HGD), does endoscopic ultrasound (EUS) provide additional information beyond esophagogastroduodenoscopy (EGD) alone?.  Gastrointest Endosc. 2008;  67 AB199
  • 21 Kwan V, Eisendrath P, Laethem J-L. et al . A prospective randomised cross-over comparison of standard and high negative pressure suction techniques for EUS-FNA.  Gastrointest Endosc. 2008;  67 AB203
  • 22 Napoleon B, Gincoul R, Lefort C. et al . Contrast enhanced EUS in solid tumors of the pancreas: results of a pilot study.  Gastrointest Endosc. 2008;  67 AB202
  • 23 Fusaroli P, Patrizi F, Grillo A. et al . Enhancing accuracy of EUS with Sonovue and a dedicated contrast harmonic echo: a preliminary experience.  Gastrointest Endosc. 2008;  67 AB201-AB202
  • 24 Hirooka Y, Itoh A, Kawashima H. et al . Use of contrast enhanced EUS in the diagnosis of pancreatic disease using perflubutane microbubbles.  Gastrointest Endosc. 2008;  67 AB214
  • 25 Fumihide I, Itoi T, Moriyasu F. et al . Usefulness of the characterization of tissue hardness of pancreatic masses using elastography EUS – first trial of the quantification using strain ratio.  Gastrointest Endosc. 2008;  67 AB212
  • 26 Poley J-W, Kuipers E. Endoscopic elastography is highly predictive of definite pathology.  Gastrointest Endosc. 2008;  67 AB99
  • 27 Sawhney M, Devarajan S, O’Farrell R. et al . Comparison of CEA and DNA analysis in 100 consecutive patients with pancreatic cysts.  Gastrointest Endosc. 2008;  67 AB209
  • 28 Ashida R, Nakata B, Shigekawa M. et al . Gene analysis of advanced pancreatic carcinoma using EUS-guided FNA with focused DNA array: possible predictor of the chemotherapeutic efficacy.  Gastrointest Endosc. 2008;  67 AB96
  • 29 Fasanella K, McGrath K, Sanders M. et al . DNA microsatellite loss in EUS-guided FNA from pancreatic endocrine tumors is associated with increased mortality.  Gastrointest Endosc. 2008;  67 AB96
  • 30 Moon S-H, Lee S, Park D. et al . Comparison of EUS-guided one step transmural drainage of pancreatic pseudocysts and conventional transmural drainage: a prospective non-blinded, single center randomised study.  Gastrointest Endosc. 2008;  67 AB225
  • 31 Kim Y, Mallery J, Lai R. EUS rendez-vous for transpapillary biliary access after unsuccessful ERCP; 9 years experience at a single center.  Gastrointest Endosc. 2008;  67 AB156
  • 32 Thong H, Lee C, Whang C. Therapeutic EUS access and/or stenting of pancreatobiliary system after failed conventional ERCP.  Gastrointest Endosc. 2008;  67 AB227
  • 33 Chang K. Endoscopic choledocho-duodenostomy for the treatment of biliary obstruction using prototype compression coil and interventional endosonography: a ”proof of principle“ canine study.  Gastrointest Endosc. 2008;  67 AB109
  • 34 Yan B, Schellenberg D, Koong A. et al . EUS-guided fiducial insertion for image guided radiation therapy of pancreatic cancer.  Gastrointest Endosc. 2008;  67 AB225
  • 35 Albashir S, Sawhney S, Pleskow D. et al . EUS-guided fiducial placement for cyberknife treatment of pancreatic cancer.  Gastrointest Endosc. 2008;  67 AB223
  • 36 Yang J, Deshpande A, Sussman D. et al . EUS-guided fiducial placement prior to targeted radiation therapy in abdominal and pelvic tumors.  Gastrointest Endosc. 2008;  67 AB202-203
  • 37 Oh H-C, Seo D, Lee S. et al . EUS guided ethanol lavage with paclitaxel injection for cystic tumors of the pancreas: follow up study with analysis of response and its predictor.  Gastrointest Endosc. 2008;  67 AB222

I. D. Penman MD, FRCP 

Gastroenterology Unit
Western General Hospital

Edinburgh
EH4 2XU
UK

Fax: +44-131-5371007

Email: ian.penman@luht.scot.nhs.uk